BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Debiopharm Acquires Global Rights for Novo Nordisk's USP1 Inhibitor Development.

Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow's standard-of-care treatments to cure can...

March 02, 2023 | News

GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service

GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, announced the expansion of its Singapor...

March 01, 2023 | News

GC Biopharma Acquires Catalyst Biosciences' Rare Disease Pipeline in Hematology

GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that it has signed an Asset Purchase ...

February 28, 2023 | News

Microbiome Connect: Asia – A Must-Attend Event for Advancing Microbiome Research and Development in Asia Pacific

Download the Agenda : https://hubs.ly/Q01Dz4xD0 Microbiome Connect is proud to announce the launch of Microbiome Connect: Asia, the premier con...

February 28, 2023 | News

Singleron Biotechnologies and Macrogen Europe announce a strategic alliance

Singleron Biotechnologies, a front-runner in single cell multi-omics analysis, and Macrogen Europe, a state-of-the-art sequencing provider of fast and...

February 27, 2023 | News

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer

The clinical trial to be conducted by Peter Mac will be the first time a CAR-T cell therapy product containing the genetic modifications incorporated into ...

February 27, 2023 | News

Malaysian Genomics to Offer World's First DNA-Driven Fertility Test

Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a strategic colla...

February 23, 2023 | News

Altos Biologics Enrolls Patients in Global Phase 3 Trial for Eylea® Biosimilar in Neovascular Age-related Macular Degeneration.

Altos Biologics, a subsidiary of Alteogen, is actively engaged in Eylea® Biosimilar (ALT-L9) clinical development and licensing-out disc...

February 23, 2023 | News

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase

In collaboration with researchers from the University of Shizuoka, Aji Bio-Pharma succeeded in developing a highly functional artificial RNA ligase using t...

February 23, 2023 | News

iGene Laboratory Announces Launch of Whole Exome Sequencing Service

FetalExome test is a whole exome sequencing (WES) test available for women with potentially complicated pregnancies. The test examines and analyses the gen...

February 21, 2023 | News

GNOMIX: Australian Study Uses MGI's DNBSEQ™ Platforms to Make Genomics Applications Accessible to All

Currently the clinical genomics landscape in Australia is strongly influenced by a couple of major players heavily driven by profit to provide a ...

February 17, 2023 | News

Oxford Nanopore Technologies teams up with UPS Healthcare to accelerate delivery of next-generation DNA sequencing technology

Oxford Nanopore Technologies today announced an extension of its collaboration with UPS Healthcare to accelerate the delivery of Oxford Nanopore DNA/RNA se...

February 16, 2023 | News

Waters Corporation is set to acquire Wyatt Technology, a company that specializes in light scattering instruments and software, and is a leader in this field.

Accelerates next phase of Waters’ strategy for growth and value creation through increased exposure in attractive, high-growth adjacent markets. W...

February 16, 2023 | News

Merck announced findings of a new analysis of long-term follow-up data from the Phase III JAVELIN Bladder 100 trial

Long-term follow-up of the Phase III JAVELIN Bladder 100 study demonstrated median overall survival from start of chemotherapy of 29.7 months among patie...

February 16, 2023 | News

Stay Connected